Filing Details
- Accession Number:
- 0000899243-17-024388
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-17 20:13:18
- Reporting Period:
- 2017-10-16
- Accepted Time:
- 2017-10-17 20:13:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1466301 | Clovis Oncology Inc. | CLVS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1268304 | C Gillian Ivers-Read | C/O Clovis Oncology, Inc. 5500 Flatiron Parkway, Suite 100 Boulder CO 80301 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-10-16 | 3,000 | $84.54 | 188,583 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $84.32 to $84.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 6, 2017.
Billionaire Hedge Funds
